Molecular survey of mcr1 and mcr2 plasmid mediated colistin resistance genes in Escherichia coli isolates of animal origin in Iran

Abstract

Objectives

The emergence of colistin-resistant Enterobacteriaceae from human and animal sources is one of the major public health concerns as colistin is the last-resort antibiotic for treating infections caused by multidrug-resistant Gram-negative bacteria. We aimed to determine the prevalence of the prototype widespread colistin resistance genes (mcr-1 and mcr-2) among commensal and pathogenic Escherichia coli strains isolated from food-producing and companion animals in Iran.

Results

A total of 607 E. coli isolates which were previously collected from different animal sources between 2008 and 2016 used to uncover the possible presence of plasmid-mediated colistin resistance genes (mcr-1 and mcr-2) by PCR. Overall, our results could not confirm the presence of any mcr-1 or mcr-2 positive E. coli among the studied isolates. It is concluded that despite the important role of food-producing animals in transferring the antibiotic resistance, they were not the main source for carriage of mcr-1 and mcr-2 in Iran until 2016. This study suggests that the other mcr variants (mcr-3 to mcr-9) might be responsible for conferring colistin resistance in animal isolates in Iran. The possible linkage between pig farming industry and high level of mcr carriage in some countries needs to be clarified in future prospective studies.

Introduction

Since the advent of antimicrobial agents for clinical practices, researchers have been faced with the emergence and spread of resistant bacteria. Mechanisms of resistance are known to favor microbial growth even in high concentration of therapeutics, causing treatment failures. This phenomenon is continuously being explored in both human and veterinary medicine. The agricultural use of antibiotics is increasing, either as growth promoters or as therapeutic agents in farm animals [1]. This could be potentially a threat to human health because resistant organisms developed in food-producing animals may confer resistance to human commensal or pathogenic strains through the food chain or direct contacts [1, 2].

Colistin is an antibiotic belonging to the polymyxins family. This drug is among the top most critically important antimicrobial agents in veterinary medicine and is active against a broad range of Gram-negative bacteria including most members of the Entrobacteriaceae family [3]. Colistin targets the polyanionic lipid A of lipopolysaccharides in the outer membrane of Gram-negative bacteria [4]. This antibiotic is widely used in poultry farms for the prevention and treatment of Enterobacteriaceae infections and is the last-resort antibiotic for treating multidrug-resistant (MDR) infections [5]. Microbial resistance to colistin occurs mostly among isolates from food animals compared to the human isolates [6,7,8,9,10]. This is due to the continuous use of colistin in veterinary medicine which has led to the higher rates of colistin resistance among isolates from food animals [8]. Moreover, the emergence of extensive drug-resistant (XDR) Gram-negative bacteria (GNB) has further increased the interest of most scientists to use colistin for the treatment of severe infections caused by these pathogens [11]. Most polymyxin resistance mechanisms are chromosomally mediated and involve modulation of a two-component regulatory system (e.g., pmrAB, phoPQ, and the negative regulator mgrB), leading to modification of lipid A with moieties including phosphoethanolamine, 4-amino-4-deoxy-l-arabinose, or, in rare instances, the total loss of lipopolysaccharides [7, 12]. Recently, it was discovered that the mcr-1 (mobile-colistin-resistance) gene is associated with colistin resistance. This gene codes for enzymes capable of modifying the LPS through the addition of phosphoethanolamine [7]. The emergence of the mcr-1 gene could be a potential threat to the efficacy of polymixins and is a global concern. This gene has been detected in various Enterobacteriaceae species from the environment, food, humans, livestock, wildlife, companion animals, rivers, and vegetables in more than 50 countries and regions [13, 14]. Reports have shown evidence of eight other plasmid-mediated colistin resistance genes which include mcr-2 to mcr-9 [15]. Although colistin has been frequently used in veterinary medicine particularly in poultry in Iran, the prevalence of colistin resistance and the carriage of mcr genes among the commensal enteric bacterial isolates from food-producing animals is poorly understood. This study was conducted to survey the frequency of the prototype widespread colistin resistance genes (mcr-1 and mcr-2) among commensal and some pathogenic enteric bacteria (E. coli) isolated from animals in Iran.

Main text

Material and methods

A total of 607 E. coli isolates were collected from different animal sources including broilers, ostriches, cattle, and sheep, pigeons and dogs. These bacteria were isolated from various regions of Iran from 2008 to 2016 in the context of different previous studies. The number of samples from each animal species and geographical regions are presented in Table 1. Briefly, the original sampling procedure included collecting fecal samples using sterile cotton swabs from the rectum of cattle, sheep and dogs, and fresh droppings of pigeons and ostriches. For the extraintestinal pathogenic E. coli strains, the samples were aseptically taken from bovine mastitis milk and liver or heart blood of commercial broilers recently died of colibacillosis. The Shiga-toxin producing E. coli (STEC) strains were confirmed by different molecular methods described previously [16]. All animals were belonging to commercial production systems except dogs and pigeons. In these cases, samples were only obtained upon the owners’ consent and approval. The samples were streaked on MacConkey agar (Merck, Germany) and a pure isolate from each sample was confirmed as E. coli using standard biochemical tests [17]. All isolates were cryopreserved in Brain Heart Infusion broth (Merck, Germany) with 30% glycerol as stocks and kept at − 70 °C. The archived strains were recovered on Brain Heart Infusion broth (BHI; Merck, Germany) after overnight culture at 37 °C with an additional streak on MacConkey agar to confirm the purity of the stocks, and a single pure colony was assessed by molecular methods; when necessary, the identity of the isolates was reassessed using sets of standard biochemical tests as described in laboratory manuals. The tests included using differential media such as Triple Sugar Iron agar, Urea agar, SIM, Citrate, and MR-VP (Merck, Germany) [17]. E. coli carrying mcr-1 (2012-60-1176-27) and E. coli containing mcr-2 (KP37) were used as reference strains and positive controls in PCR reactions. All strains were tested by two sets of conventional PCR assays targeting the mcr-1 and mcr-2 resistance genes. DNA templates were extracted by boiling method as described previously [18]. Briefly, a loopful from an overnight culture on Luria Bertani agar (Merck, Germany) was suspended in 350 μl molecular grade water. Then, the suspension was boiled for 10 min and after cooling on ice, centrifuged for 5 min at 10,000×g and the supernatants were used as templates. For PCR reactions, a ready-to-use Red PCR Master Mix (Ampliqon, Denmark) containing 1.5 mM MgCl₂, 0.2 mM dNTP and 0.1% Tween 20 was used. The final concentration for each primer was 0.3 μM, and 3 μl of crude DNA was used as template. The primers were (5′-CGGTCAGTCCGTTTGTTC -3′/5′-CTTGGTCGGTCTGTAGGG-3′) for mcr-1, and (5′-TGTTGCTTGTGCCGATTGGA -3′/5′-AGATGGTATTGTTGGTTGCTG-3′) for mcr-2 as described before [7, 19]. Thermal cycling conditions were conducted in TC-3000 cycler (Techne, UK) under the following conditions: for the mcr-1 amplification, one cycle of denaturation at 94 °C for 5 min, followed by 30 cycles of denaturation at 94 °C for 30 s, annealing at 58 °C for 90 s and elongation at 72 °C for 60 s, and a final cycle of elongation at 72 °C for 7 min was applied. The amplification of mcr-2 included 33 cycles of 95, 65 and 72 °C, all for 60 s. The amplification output was visualized by electrophoresis on 1.5% agarose gel at 100 V followed by staining in DNA safe stain (Cinnagen, Iran).

Table 1 The origin and characteristics of the 607 studied E. coli isolates

Results and discussion

In the present survey, no mcr-1/mcr-2 harboring E. coli were found among the 607 tested isolates of animal origin which belonged to ten provinces in Iran. Antibiotic consumption or administration in animals is known as a major contributor to the development of antimicrobial resistance in humans. The recent emergence of clinically important bacteria such as mcr-positive colistin-resistant E. coli in humans has been mostly associated with food-producing animals [20]. Globally, colistin is among the widely used antibiotics in veterinary clinical practices. The mcr genes associated with colistin resistance in Enterobacteriaceae are widespread and have been reported in veal, swine, and poultry in different countries [7, 21,22,23]. The aforesaid resistance has already become established in livestock, posing a potential threat to consumers through eating contaminated meat and other products [24].

Generally, few studies have investigated colistin resistance by molecular methods in E. coli isolates from animals in Iran. Based on the CLSI guidelines, the disc diffusion method cannot reflect resistance to colistin or harboring mobile genetic mcr elements, suggesting that some of the previous colistin susceptibility studies in Iran could be misleading. In this study, a PCR-based detection method was performed to survey the mcr-1 and mcr-2 presence among an extensive collection of E. coli strains, and none of the tested isolates carried the targeted genes. As mentioned, these strains were recovered from 2008 to 2016 from different animal sources. In a similar study, no colistin-resistant E. coli isolate was detected in poultry in the northwest of Iran [25]. Another study from southwest Iran reported 1.2% of E. coli and 0.4% of K. pneumoniae isolates from human samples carried mcr-1 gene while mcr-2 was not detected [26]. Consistently, in a recent study, no mcr-1 and mcr-2 genes were identified from Enterobacteriaceae isolates of human origin in the northwest of Iran [27]. Despite the regular administration of colistin in farm animals, the absence of mcr-1 and mcr-2 genes suggested that these genes were not widespread among animal sources in Iran at least until few years ago. Additionally, these findings partially support the low prevalence of mcr genes in human and veterinary clinical isolates in previous studies conducted in Iran.

The mcr-1, as a prototype of the plasmid resistance gene for colistin, was initially reported in E. coli from livestock, food, and humans in China in 2015 [28]. A study in China described a low prevalence of colistin-resistance E. coli among cattle (0.9%); while in comparison, such resistance among E. coli isolated from chickens and pigs was high (14% among chickens and 24% among pigs) [10]. The gene was also reported from Denmark and other countries confirming worldwide dissemination of the gene from various sources [23, 29]. A low prevalence of mcr-1 (1%) was detected in Salmonella from poultry meat (K. Veldman et al., unpublished data), E. coli isolates from livestock (1%) and meat (2%) in the Netherlands [29]. In Germany, a recent study investigating a total of 580 E. coli isolates from chicken meat, indicated a decreasing prevalence of mcr-1, from 8.1% in 2011 to 0.5% in 2014 based on isolate screening [30]. At much lower rates, the presence of mcr-1 was confirmed in isolates from poultry and other meat products from Europe in other studies [29]. The mcr-1-harboring E. coli isolates (19.5%) in chicken meat was also reported from South America based on a selective culture approach [31]. Similar reports demonstrated the presence of mcr-1 in an E. coli isolate from a cow displaying subclinical mastitis, suggesting that mcr associated resistance also emerged in Egypt despite showing a very low prevalence in this country [32]. After reporting the first mcr-1, the mcr-2 plasmid-mediated colistin resistance was subsequently described in E. coli from cattle and pigs in Belgium [19]. In China, the prevalence of mcr-2 in colistin-resistant E. coli isolates from pigs, chickens and cattle was 46.82%, 14.90%, and 19.05%, respectively, compared to the higher prevalence of mcr-1 in these species [33]. Other studies reported no mcr-2 in E. coli isolates from cattle, swine, and broilers, while the prevalence of mcr-1 slightly increased [9, 34]. Additionally, the mcr-2 was not detected in any poultry isolates in Romania [35].

It seems that the pig industry may play an important role in colistin resistance emergence and spread. In Portugal, 98% of pigs tested positive for mcr-1 harboring Enterobacteriaceae isolates (mainly E. coli), while no mcr-2 carrying isolate was identified [36]. Accordingly, a recent study on the prevalence of colistin-resistant bacteria in Ecuador showed that 41.9% of E. coli isolates from chicken and pigs harbored mcr-1 [37]. Another study in Spain revealed that the prevalence of colistin-resistant E. coli was 76.9% in pigs [15]. Also, a high prevalence of E. coli harboring mcr genes in pigs was detected in China (mcr-1 = 79.2%, mcr-2 = 56.3%) [38]. Other studies described the occurrence of mcr-1 in swine; for example, the prevalence in Europe ranged from 0.5 to 13.5% [36]. Therefore, based on the available literature, pigs have been an important reservoir of colistin plasmid-mediated resistance, and the absence of swine industrial farming in Iran or other countries like Egypt could be a possible reason for the low prevalence of mcr-1 and mcr-2 genes in food animals. It should be noted that many novel mcr variants need to be targeted in future studies in Iran to obtain a more integrated view on colistin resistance. Also, the presence of possible new mcr variants in Iran should be considered.

In conclusion, the results of this study indicated that despite the important role of animals in transferring antimicrobial resistance, we need to have a more integrated perspective about this global issue [39,40,41]. Additionally, in order to reduce the probability of transmitting resistant bacteria from animals to humans, the monitoring and antibiotic stewardship strategies should be improved.

Limitations

As we described in Table 1, the studied samples in this survey originated from ten provinces in Iran, but we still need to carry out more sophisticated comprehensive studies to confirm the absence of mcr-1 and mcr-2 colistin resistance in the animal population.